Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence

Bibliographic Details
Title: Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence
Authors: Christ, Sebastian M. a, b, ⁎, Youssef, Gilbert c, Tanguturi, Shyam K. a, Cagney, Daniel a, Shi, Diana a, McFaline-Figueroa, J. Ricardo c, Chukwueke, Ugonma c, Lee, Eudocia Q. c, Hertler, Caroline d, Andratschke, Nicolaus b, Weller, Michael e, Reardon, David A. c, Haas-Kogan, Daphne a, Guckenberger, Matthias b, Wen, Patrick Y. c, Rahman, Rifaquat a
Source: In Clinical and Translational Radiation Oncology January 2024 44
Database: ScienceDirect
More Details
ISSN:24056308
DOI:10.1016/j.ctro.2023.100697
Published in:Clinical and Translational Radiation Oncology
Language:English